The course is aimed at professionals in the biopharmaceutical industry/health technologies, professionals in the healthcare/hospital field and consultants and other professionals related to healthcare in general, who are interested in acquiring knowledge about market access and/or furthering their knowledge on the subject.
The objective of the course is to enable the participating students to represent their company to Health/Health stakeholders, to demonstrate and justify the value of medicines and/or health technologies, to critically review and adapt value dossiers and other documents to the national, regional and/or local environment, to become valid internal interlocutors who analyse health and pharmaceutical policies.
For more information, please visit